Table 4 The impact of initial treatment strategy on health care use
| Â | Hospital stays, unplanned | |||
|---|---|---|---|---|
| Â | Unadjusted | Adjusted* | ||
Initial treatment | IRR (95% CI) | p-value | IRR (95% CI) | p-value |
 No tumour-directed | 1.70 (1.57–1.85) | < 0.001 | 1.44 (1.30–1.59) | < 0.001 |
 Palliative | 1.67 (1.59–1.75) | < 0.001 | 1.31 (1.22–1.41) | < 0.001 |
 Curative | 1.00 (reference) |  | 1.00 (reference) |  |
| Â | Hospital stays, planned | |||
| Â | Unadjusted | Adjusted* | ||
Initial treatment | IRR (95% CI) | p-value | IRR (95% CI) | p-value |
 No tumour-directed | 0.67 (0.58–0.78) | < 0.001 | 0.69 (0.58–0.82) | < 0.001 |
 Palliative | 1.05 (0.98–1.12) | 0.179 | 0.93 (0.84–1.02) | 0.133 |
 Curative | 1.00 (reference) |  | 1.00 (reference) |  |
| Â | Visits, specialist outpatient care, unplanned | |||
| Â | Unadjusted | Adjusted* | ||
Initial treatment | IRR (95% CI) | p-value | IRR (95% CI) | p-value |
 No tumour-directed | 1.11 (0.99–1.25) | 0.067 | 1.24 (1.08–1.42) | 0.002 |
 Palliative | 1.53 (1.44–1.63) | < 0.001 | 1.54 (1.42–1.68) | < 0.001 |
 Curative | 1.00 (reference) |  | 1.00 (reference) |  |
| Â | Visits, specialist outpatient care, planned | |||
| Â | Unadjusted | Adjusted* | ||
Initial treatment | IRR (95% CI) | p-value | IRR (95% CI) | p-value |
 No tumour-directed | 0.47 (0.44–0.50) | < 0.001 | 0.55 (0.51–0.59) | < 0.001 |
 Palliative | 1.28 (1.25–1.31) | < 0.001 | 1.13 (1.09–1.18) | < 0.001 |
 Curative | 1.00 (reference) |  | 1.00 (reference) |  |